Can-Fite BioPharma Ltd. (CANF)
NYSEAMERICAN: CANF · Real-Time Price · USD
2.010
0.00 (0.00%)
Nov 21, 2024, 10:58 AM EST - Market open
Can-Fite BioPharma Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Can-Fite BioPharma stock have an average target of 14, with a low estimate of 10 and a high estimate of 18. The average target predicts an increase of 596.52% from the current stock price of 2.01.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for CANF stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +795.52% | Nov 12, 2024 |
| EF Hutton | EF Hutton | Strong Buy Maintains $10 | Strong Buy | Maintains | $10 | +397.51% | Oct 10, 2024 |
| EF Hutton | EF Hutton | Strong Buy Maintains $10 | Strong Buy | Maintains | $10 | +397.51% | Sep 24, 2024 |
| EF Hutton | EF Hutton | Strong Buy Maintains $10 | Strong Buy | Maintains | $10 | +397.51% | Aug 30, 2024 |
| EF Hutton | EF Hutton | Strong Buy Initiates $10 | Strong Buy | Initiates | $10 | +397.51% | Jul 17, 2024 |
Financial Forecast
Revenue This Year
3.79M
from 743.00K
Increased by 409.56%
Revenue Next Year
3.79M
from 3.79M
EPS This Year
-4.88
from -0.01
EPS Next Year
-4.20
from -4.88
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 3.9M | 3.9M | 3.1M |
| Avg | 3.8M | 3.8M | 3.0M |
| Low | 3.6M | 3.6M | 2.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 424.5% | 2.9% | -18.3% |
| Avg | 409.6% | - | -20.7% |
| Low | 389.5% | -3.9% | -23.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -5.03 | -4.33 | -7.73 |
| Avg | -4.88 | -4.20 | -7.51 |
| Low | -4.69 | -4.04 | -7.22 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.